High-dose chemotherapy followed by autologous stem cell transplantation as a first-line therapy for high-risk primary breast cancer: a meta-analysis.
<h4>Background and objectives</h4>Several trials have generated conflicting results about the results of high-dose chemotherapy followed by autologous stem cell transplantation (HDCT) for primary breast cancer. This meta-analysis summarizes the available evidence from all suitable studie...
Guardado en:
Autores principales: | Jing Wang, Qiguo Zhang, Rongfu Zhou, Bing Chen, Jian Ouyang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b58ace42c0a8424a8e5e87fb49ef8042 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience
por: Nikita E. Mochkin, et al.
Publicado: (2020) -
Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies
por: Kojima S, et al.
Publicado: (2014) -
Ice-cream used as cryotherapy during high-dose melphalan conditioning reduces oral mucositis after autologous hematopoietic stem cell transplantation
por: Marcin Jasiński, et al.
Publicado: (2021) -
First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis
por: Christian Möhring, et al.
Publicado: (2021) -
AUTOLOGOUS STEM CELL TRANSPLANTATION AND IMMUNOMODULATION IN AMYOTROPHIC LATERAL SCLEROSIS
por: David Uriel Ayllón Álvarez, et al.
Publicado: (2021)